Compile Data Set for Download or QSAR
Report error Found 63 Enz. Inhib. hit(s) with all data for entry = 12920
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740656(US20250154162, Example 25)
Affinity DataIC50: 0.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740655(US20250154162, Example 24)
Affinity DataIC50: 0.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740691(US20250154162, Example 60)
Affinity DataIC50: 0.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740678(US20250154162, Example 47)
Affinity DataIC50: 0.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740654(US20250154162, Example 23)
Affinity DataIC50: 0.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740652(US20250154162, Example 21)
Affinity DataIC50: 0.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740664(US20250154162, Example 33)
Affinity DataIC50: 0.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740665(US20250154162, Example 34)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740657(US20250154162, Example 26)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740658(US20250154162, Example 27)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740659(US20250154162, Example 28)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740660(US20250154162, Example 29)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740661(US20250154162, Example 30)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740662(US20250154162, Example 31)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740695(US20250154162, Example 64)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740666(US20250154162, Example 35)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740667(US20250154162, Example 36)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740670(US20250154162, Example 39)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740671(US20250154162, Example 40)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740673(US20250154162, Example 42)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740676(US20250154162, Example 45)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740677(US20250154162, Example 46)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740693(US20250154162, Example 62)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740694(US20250154162, Example 63)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740651(US20250154162, Example 20)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740634(US20250154162, Example 2)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740637(US20250154162, Example 5)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740638(US20250154162, Example 6)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740639(US20250154162, Example 7)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740642(US20250154162, Example 10)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740643(US20250154162, Example 11)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740644(US20250154162, Example 12)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740646(US20250154162, Example 15)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740645(US20250154162, Example 13)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740653(US20250154162, Example 22)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740648(US20250154162, Example 17)
Affinity DataIC50: 1.75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740633(US20250154162, Example 1)
Affinity DataIC50: 6.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740692(US20250154162, Example 61)
Affinity DataIC50: 6.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740650(US20250154162, Example 19)
Affinity DataIC50: 6.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740649(US20250154162, Example 18)
Affinity DataIC50: 6.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740675(US20250154162, Example 44)
Affinity DataIC50: 6.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740640(US20250154162, Example 8)
Affinity DataIC50: 6.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740663(US20250154162, Example 32)
Affinity DataIC50: 6.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740668(US20250154162, Example 37)
Affinity DataIC50: 6.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740669(US20250154162, Example 38)
Affinity DataIC50: 6.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740674(US20250154162, Example 43)
Affinity DataIC50: 6.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740672(US20250154162, Example 41)
Affinity DataIC50: 6.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740641(US20250154162, Example 9)
Affinity DataIC50: 6.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740679(US20250154162, Example 48)
Affinity DataIC50: 17.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Scinnohub Pharmaceutical

US Patent
LigandPNGBDBM740635((7-amino-3-phenylthieno[2,3-b]pyrazin-6-yl) (4-flu...)
Affinity DataIC50: 17.5nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/16/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 63 total ) | Next | Last >>
Jump to: